Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS 12: Clinical cancer nursing based on evidence

2811 - EONS - Nurse-led consultations for patients with gynecological cancer receiving concurrent cisplatin - a pilot study.

Date

29 Sep 2019

Session

EONS 12: Clinical cancer nursing based on evidence

Presenters

Mille Christiansen

Citation

Annals of Oncology (2019) 30 (suppl_5): v836-v845. 10.1093/annonc/mdz276

Authors

M.G. Christiansen1, H. Roed2, C. Phanareth1, K. Piil1

Author affiliations

  • 1 Oncology, Rigshospitalet, DK-2100 - Copenhagen/DK
  • 2 Oncology, Rigshospitalet, 2100 - Copenhagen/DK

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2811

Background

Optimal management of symptoms is essential for the patientś adherence to the treatment schedule and quality of life. Nurses can play a crucial role in identifying the patient’s symptoms, side effects, needs and to provide support and guidance during treatment. At the Department of Oncology we replaced physician-led consultations with systematic nurse-led consultations. This study seeks to evaluate the feasibility of systematic nurse-led consultations among patients with cervical, vulvar or vaginal cancer during radiotherapy prior to the weekly treatment with cisplatin.

Methods

This pilot study aimed to evaluate the feasibility, acceptability and safety from systematic nurse-led consultations among patients receiving curative concurrent chemotherapy. Patients who participated in minimum 4-6 nurse-led consultations responded to a self-developed questionnaire evaluating the consultations. The questionnaire consisted of 21 items on a 5-point Likert scale and ranged from very satisfied to very dissatisfied. Further, a focus group interview with nurse specialists (n = 4) was conducted.

Results

Patients (n = 50) who participated in nurse-led consultation from March 2018 to April 2019 fulfilled the questionnaire. The nurse-led consultations were evaluated as being feasible with no adverse events reported. The majority (94 %) were very satisfied or satisfied (6%) with nurse-led consultations. They received sufficient information about self-management strategies and side-effects. They were very satisfied (87,5%) or satisfied (12,5%) with the information and guidance provided by the nurse specialists. The focus group interview revealed that the nurse specialists (n = 4) appreciated the use of their competencies and e.g. valued the autonomy and holistic approach provided to their patients.

Conclusions

Systematic nurse-led consultations during concurrent chemoradiation trajectory of cervical, vulvar or vaginal cancer is feasible, acceptable and safe for both patients and the nurse specialists.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Rigshospitalet, Onkologisk Klinik.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.